Files in this item
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe : multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021
Item metadata
dc.contributor.author | Kissling, Esther | |
dc.contributor.author | Hooiveld, Mariette | |
dc.contributor.author | Martinez-Baz, Ivan | |
dc.contributor.author | Mazagatos, Clara | |
dc.contributor.author | William, Naoma | |
dc.contributor.author | Vilcu, Ana Maria | |
dc.contributor.author | Kooijman, Marjolein N. | |
dc.contributor.author | Ilic, Maja | |
dc.contributor.author | Domegan, Lisa | |
dc.contributor.author | Machado, Ausenda | |
dc.contributor.author | De Lusignan, Simon | |
dc.contributor.author | Lazar, Mihaela | |
dc.contributor.author | Meijer, Adam | |
dc.contributor.author | Brytting, Mia | |
dc.contributor.author | Casado, Itziar | |
dc.contributor.author | Larrauri, Amparo | |
dc.contributor.author | Murray, Josephine L.K. | |
dc.contributor.author | Behillil, Sylvie | |
dc.contributor.author | De Gier, Brechje | |
dc.contributor.author | Mlinaric, Ivan | |
dc.contributor.author | O'Donnell, Joan | |
dc.contributor.author | Rodrigues, Ana Paula | |
dc.contributor.author | Tsang, Ruby | |
dc.contributor.author | Timnea, Olivia | |
dc.contributor.author | de Lange, Marit | |
dc.contributor.author | Riess, Maximilian | |
dc.contributor.author | Castilla, Jesus | |
dc.contributor.author | Pozo, Francisco | |
dc.contributor.author | Hamilton, Mark | |
dc.contributor.author | Falchi, Alessandra | |
dc.contributor.author | Knol, Mirjam J. | |
dc.contributor.author | Filipovic, Sanja Kurecic | |
dc.contributor.author | Dunford, Linda | |
dc.contributor.author | Guiomar, Raquel | |
dc.contributor.author | Cogdale, Jade | |
dc.contributor.author | Cherciu, Carmen | |
dc.contributor.author | Jansen, Tessa | |
dc.contributor.author | Enkirch, Theresa | |
dc.contributor.author | Basile, Luca | |
dc.contributor.author | Connell, Jeff | |
dc.contributor.author | Gomez, Veronica | |
dc.contributor.author | Martin, Virginia Sandonis | |
dc.contributor.author | Bacci, Sabrina | |
dc.contributor.author | Rose, Angela M.C. | |
dc.contributor.author | Celentano, Lucia Pastore | |
dc.contributor.author | Valenciano, Marta | |
dc.contributor.author | I-MOVE-COVID-19 primary care study team | |
dc.date.accessioned | 2022-09-23T11:30:10Z | |
dc.date.available | 2022-09-23T11:30:10Z | |
dc.date.issued | 2022-05-26 | |
dc.identifier | 280688588 | |
dc.identifier | 187b6a59-4203-4b35-96d7-069fe86b9b2d | |
dc.identifier | 85130872682 | |
dc.identifier | 35620997 | |
dc.identifier.citation | Kissling , E , Hooiveld , M , Martinez-Baz , I , Mazagatos , C , William , N , Vilcu , A M , Kooijman , M N , Ilic , M , Domegan , L , Machado , A , De Lusignan , S , Lazar , M , Meijer , A , Brytting , M , Casado , I , Larrauri , A , Murray , J L K , Behillil , S , De Gier , B , Mlinaric , I , O'Donnell , J , Rodrigues , A P , Tsang , R , Timnea , O , de Lange , M , Riess , M , Castilla , J , Pozo , F , Hamilton , M , Falchi , A , Knol , M J , Filipovic , S K , Dunford , L , Guiomar , R , Cogdale , J , Cherciu , C , Jansen , T , Enkirch , T , Basile , L , Connell , J , Gomez , V , Martin , V S , Bacci , S , Rose , A M C , Celentano , L P , Valenciano , M & I-MOVE-COVID-19 primary care study team 2022 , ' Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe : multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021 ' , Eurosurveillance , vol. 27 , no. 21 , A1 . https://doi.org/10.2807/1560-7917.ES.2022.27.21.2101104 | en |
dc.identifier.issn | 1025-496X | |
dc.identifier.other | ORCID: /0000-0002-1511-7944/work/116910277 | |
dc.identifier.uri | https://hdl.handle.net/10023/26061 | |
dc.description | This project received funding from the European Centre for Disease Prevention and Control (ECDC) under the contract ECD.11486. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101003673. | en |
dc.description.abstract | Introduction : In July and August 2021, the SARS-CoV-2 Delta variant dominated in Europe. Aim: Using a multicentre test-negative study, we measured COVID-19 vaccine effectiveness (VE) against symptomatic infection. Methods : Individuals with COVID-19 or acute respiratory symptoms at primary care/community level in 10 European countries were tested for SARS-CoV-2. We measured complete primary course overall VE by vaccine brand and by time since vaccination. Results : Overall VE was 74% (95% CI: 69-79), 76% (95% CI: 71-80), 63% (95% CI: 48-75) and 63% (95% CI: 16-83) among those aged 30-44, 45-59, 60-74 and ≥ 75 years, respectively. VE among those aged 30-59 years was 78% (95% CI: 75-81), 66% (95% CI: 58-73), 91% (95% CI: 87-94) and 52% (95% CI: 40-61), for Comirnaty, Vaxzevria, Spikevax and COVID-19 Vaccine Janssen, respectively. VE among people 60 years and older was 67% (95% CI: 52-77), 65% (95% CI: 48-76) and 83% (95% CI: 64-92) for Comirnaty, Vaxzevria and Spikevax, respectively. Comirnaty VE among those aged 30-59 years was 87% (95% CI: 83-89) at 14-29 days and 65% (95% CI: 56-71%) at ≥ 90 days between vaccination and onset of symptoms. Conclusions : VE against symptomatic infection with the SARS-CoV-2 Delta variant varied among brands, ranging from 52% to 91%. While some waning of the vaccine effect may be present (sample size limited this analysis to only Comirnaty), protection was 65% at 90 days or more between vaccination and onset. | |
dc.format.extent | 13 | |
dc.format.extent | 642609 | |
dc.language.iso | eng | |
dc.relation.ispartof | Eurosurveillance | en |
dc.subject | QR355 Virology | en |
dc.subject | RA0421 Public health. Hygiene. Preventive Medicine | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject | Virology | en |
dc.subject | Epidemiology | en |
dc.subject | Public Health, Environmental and Occupational Health | en |
dc.subject | 3rd-DAS | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | NIS | en |
dc.subject.lcc | QR355 | en |
dc.subject.lcc | RA0421 | en |
dc.subject.lcc | RM | en |
dc.title | Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe : multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021 | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews. School of Medicine | en |
dc.contributor.institution | University of St Andrews. Education Division | en |
dc.identifier.doi | 10.2807/1560-7917.ES.2022.27.21.2101104 | |
dc.description.status | Peer reviewed | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.